Skip Navigation



Nucleic Acids Research Advance Access published online on June 22, 2007

Nucleic Acids Research, doi:10.1093/nar/gkm461
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (3166K) Freely available
Right arrow Screen PDF (503K) Freely available
Right arrow Supplementary Material
Right arrowOA All Versions of this Article:
35/13/4542    most recent
gkm461v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Viegas, M. H.
Right arrow Articles by Kulozik, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viegas, M. H.
Right arrow Articles by Kulozik, A. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


RNA

The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway

Marcelo H. Viegas1,2, Niels H. Gehring1,2, Stephen Breit1, Matthias W. Hentze2,3,* and Andreas E. Kulozik1,2,*

1Department of Pediatric Oncology, Hematology and Immunology, Children's Hospital, University of Heidelberg, Im Neuenheimer Feld 150, 69120 Heidelberg, Germany, 2Molecular Medicine Partnership Unit (University of Heidelberg and European Molecular Biology Laboratory) and 3European Molecular Biology Laboratory, Gene Expression Unit, Meyerhofstr 1, 69117 Heidelberg, Germany

*To whom correspondence should be addressed. Tel: +49 6221 56 2303; Fax: +49 6221 56 4559; Email: andreas.kulozik{at}med.uni-heidelberg.de Correspondence may also be addressed to Matthias W. Hentze. Tel: +49 6221 387 501; Fax: +49 6221 387 518; Email: hentze{at}embl.de

Received February 13, 2007. Revised May 9, 2007. Accepted May 27, 2007.

Nonsense-mediated mRNA decay (NMD) is a molecular pathway of mRNA surveillance that ensures rapid degradation of mRNAs containing premature translation termination codons (PTCs) in eukaryotes. NMD has been shown to also regulate normal gene expression and thus emerged as one of the key post-transcriptional mechanisms of gene regulation. Recently, NMD efficiency has been shown to vary between cell types and individuals thus implicating NMD as a modulator of genetic disease severity. We have now specifically analysed the molecular mechanism of variable NMD efficiency and first established an assay system for the quantification of NMD efficiency, which is based on carefully validated cellular NMD target transcripts. In a HeLa cell model system, NMD efficiency is shown to be remarkably variable and to represent a stable characteristic of different strains. In one of these strains, low NMD efficiency is shown to be functionally related to the reduced abundance of the exon junction component RNPS1. Furthermore, restoration of functional RNPS1 expression, but not of NMD-inactive mutant proteins, also restores efficient NMD in this model. We conclude that cellular concentrations of RNPS1 can modify NMD efficiency and propose that cell type specific co-factor availability represents a novel principle that controls NMD.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
A. Tsakiridis, E. Tzouanacou, A. Rahman, D. Colby, R. Axton, I. Chambers, V. Wilson, L. Forrester, and J. M. Brickman
Expression-independent gene trap vectors for random and targeted mutagenesis in embryonic stem cells
Nucleic Acids Res., October 1, 2009; 37(19): e129 - e129.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
K. M. Kim, H. Cho, K. Choi, J. Kim, B.-W. Kim, Y.-G. Ko, S. K. Jang, and Y. K. Kim
A new MIF4G domain-containing protein, CTIF, directs nuclear cap-binding protein CBP80/20-dependent translation
Genes & Dev., September 1, 2009; 23(17): 2033 - 2045.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
C. Gong, Y. K. Kim, C. F. Woeller, Y. Tang, and L. E. Maquat
SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs
Genes & Dev., January 1, 2009; 23(1): 54 - 66.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. C. Schoning, C. Streitner, I. M. Meyer, Y. Gao, and D. Staiger
Reciprocal regulation of glycine-rich RNA-binding proteins via an interlocked feedback loop coupling alternative splicing to nonsense-mediated decay in Arabidopsis
Nucleic Acids Res., December 1, 2008; 36(22): 6977 - 6987.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.